These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8898005)

  • 21. Renal actions of the selective angiotensin AT2 receptor ligands CGP 42112B and PD 123319 in the sodium-depleted rat.
    Macari D; Bottari S; Whitebread S; De Gasparo M; Levens N
    Eur J Pharmacol; 1993 Nov; 249(1):85-93. PubMed ID: 8282023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in AT2 -receptor stimulation between AT1 -receptor blockers valsartan and losartan quantified by renal interstitial fluid cGMP.
    Siragy HM; El-Kersh MA; De Gasparo M; Webb RL; Carey RM
    J Hypertens; 2002 Jun; 20(6):1157-63. PubMed ID: 12023686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal actions of the angiotensin AT2 receptor ligands CGP 42112 and PD 123319 after blockade of the renin-angiotensin system.
    Macari D; Whitebread S; Cumin F; De Gasparo M; Levens N
    Eur J Pharmacol; 1994 Jun; 259(1):27-36. PubMed ID: 7957590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin-converting enzyme inhibition potentiates angiotensin II type 1 receptor effects on renal bradykinin and cGMP.
    Siragy HM; de Gasparo M; El-Kersh M; Carey RM
    Hypertension; 2001 Aug; 38(2):183-6. PubMed ID: 11509473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of angiotensin AT1 and AT2 receptors in mediating the renal effects of angiotensin II in the anaesthetized dog.
    Clark KL; Robertson MJ; Drew GM
    Br J Pharmacol; 1993 May; 109(1):148-56. PubMed ID: 8495237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of angiotensin II type 1 receptor antagonist on urinary prostaglandin E2 excretion following furosemide in rats.
    Fujimura A; Sudoh T; Ebihara A
    Life Sci; 1994; 55(9):707-11. PubMed ID: 8065233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the angiotensin II receptor antagonist Losartan (DuP 753/MK 954) on arterial blood pressure, heart rate, plasma concentrations of angiotensin II and renin and the pressor response to infused angiotensin II in the salt-deplete dog.
    MacFadyen RJ; Tree M; Lever AF; Reid JL
    Clin Sci (Lond); 1992 Nov; 83(5):549-56. PubMed ID: 1335390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
    Ruan X; Wagner C; Chatziantoniou C; Kurtz A; Arendshorst WJ
    J Clin Invest; 1997 Mar; 99(5):1072-81. PubMed ID: 9062366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of the renin-angiotensin and kallikrein-kinin systems to short-term variability of blood pressure in two-kidney, one-clip hypertensive rats.
    Ponchon P; Elghozi JL
    Eur J Pharmacol; 1996 Feb; 297(1-2):61-70. PubMed ID: 8851167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal hemodynamic and excretory responses to PD 123319 and losartan, nonpeptide AT1 and AT2 subtype-specific angiotensin II ligands.
    Keiser JA; Bjork FA; Hodges JC; Taylor DG
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1154-60. PubMed ID: 1527720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Losartan, a nonpeptide angiotensin II receptor antagonist, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs.
    Suzuki Y; Matsumura Y; Egi Y; Morimoto S
    J Pharmacol Exp Ther; 1992 Dec; 263(3):956-63. PubMed ID: 1469652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide alters renal function and guanosine 3',5'-cyclic monophosphate.
    Siragy HM; Johns RA; Peach MJ; Carey RM
    Hypertension; 1992 Jun; 19(6 Pt 2):775-9. PubMed ID: 1317356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic kinin blockade and effect of ramipril in renal adaptation to sodium restriction.
    Jover B; Hérizi A; Mimran A
    Hypertension; 1996 Jan; 27(1):79-84. PubMed ID: 8591893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal-specific actions of angiotensin II receptor antagonism in the anesthetized dog.
    Chan DP; Sandok EK; Aarhus LL; Heublein DM; Burnett JC
    Am J Hypertens; 1992 Jun; 5(6 Pt 1):354-60. PubMed ID: 1524759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats.
    Siragy HM; de Gasparo M; Carey RM
    Hypertension; 2000 May; 35(5):1074-7. PubMed ID: 10818067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice.
    Abadir PM; Carey RM; Siragy HM
    Hypertension; 2003 Oct; 42(4):600-4. PubMed ID: 12953015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
    Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril.
    Fenoy FJ; Scicli G; Carretero O; Roman RJ
    Hypertension; 1991 Jun; 17(6 Pt 2):1038-44. PubMed ID: 1646165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of ANG II receptor and its mRNA in normal rat by low-protein feeding.
    Benabe JE; Wang S; Wilcox JN; Martinez-Maldonado M
    Am J Physiol; 1993 Nov; 265(5 Pt 2):F660-9. PubMed ID: 8238546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of losartan and enalapril on renal adaptation sodium restriction in rat.
    Jover B; Saladini D; Nafrialdi N; Dupont M; Mimran A
    Am J Physiol; 1994 Aug; 267(2 Pt 2):F281-8. PubMed ID: 8067389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.